ResMed Inc

$219.94
(as of Mar 28, 7:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for ResMed Inc

Stock Price
$219.94
Ticker Symbol
RMD
Exchange
NYSE

Industry Information for ResMed Inc

Sector
Healthcare
Industry
Medical Instruments & Supplies

Company Description for ResMed Inc

Country
USA
Full Time Employees
0

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Fundamentals for ResMed Inc

Market Capitalization
$32,301,930,496
EBITDA
$1,712,289,024
Dividends per Share
$2.02
P/E Ratio
25.97
Forward P/E Ratio
21.46
Earnings per Share
$8.47
Earnings per Share Estimate Next Year
Profit Margin
25.35%
Shares Outstanding
146,867,008
Percent Owned by Insiders
0.77%
Percent Owned by Institutions
62.85%
52-Week High
52-Week Low

Technical Indicators for ResMed Inc

50-Day Moving Average
200-Day Moving Average
RSI
41.36
5.82

Analyst Ratings for ResMed Inc

Strong Buy
6
Buy
3
Hold
8
Sell
0
Strong Sell
1

News About ResMed Inc

Mar 28, 2025, 7:04 AM EST
Markets have proven highly volatile in the first two months of President Trump’s new term of office, as investors are worried about everything from trade and tariff policy to increased inflation to geopolitics. See more.
Mar 26, 2025, 10:37 AM EST
We recently published a list of Jim Cramer Recently Talked About These 12 Companies. See more.
Mar 21, 2025, 5:06 AM EST
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers See more.
Mar 20, 2025, 10:15 AM EST
Morgan Stanley analyst David Bailey initiated coverage of ResMed (RMD) with an Overweight rating and $280 price target The company has a market-leading position in the obstructive sleep apnea market and valuations appear attractive at current levels, with a strong balance sheet position and the highest ROIC across the firm’s Australian Healthcare industry sector coverage, the analyst tells investors. See more.